U.S. market Closed. Opens in 13 hours 53 minutes

TRML | Tourmaline Bio, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue33.00K6.00K623.00K447.00K379.00K
Gross Profit-33.00K-6.00K-623.00K-447.00K-379.00K
Operating Expenses45.41M19.70M904.0022.24M18.00M
Selling, General & Admin13.04M2.17M692.006.96M4.63M
Research & Development32.37M17.53M212.0015.28M13.37M
Other Operating ExpensesN/AN/AN/AN/AN/A
Operating Income-45.41M-19.70M-904.00-22.68M-18.38M
Other Expenses / Income3.29MN/A-47.83M-23.00K223.00K
Before Tax Income-42.12M-19.70M-904.00-22.71M-18.16M
Income Tax ExpensesN/AN/A-47.21MN/AN/A
Net Income-42.12M-19.70M-904.00-22.71M-18.16M
Interest ExpensesN/AN/AN/A23.00KN/A
Basic Shares Outstanding4.75M20.34M10.88M668.51K4.13M
Diluted Shares Outstanding4.75M20.34M10.88M668.51K4.13M
EBITDA-45.38M-19.70M-46.88M-22.24M-17.78M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-42.12M-19.70M-47.21M-22.68M-18.16M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙